Research Progress on Molecular Subtyping and Modern Treatment of Triple-Negative Breast Cancer

Breast cancer has become the most common malignant tumor worldwide. Triple-negative breast cancer (TNBC) is a type of breast cancer that is negative for estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2). Compared with other molecular subtypes of...

Descripción completa

Detalles Bibliográficos
Autores principales: Tong, Ling, Yu, Xiangling, Wang, Shan, Chen, Ling, Wu, Yibo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10461741/
https://www.ncbi.nlm.nih.gov/pubmed/37644916
http://dx.doi.org/10.2147/BCTT.S426121

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10461741/
https://www.ncbi.nlm.nih.gov/pubmed/37644916
http://dx.doi.org/10.2147/BCTT.S426121

Ejemplares similares